Literature DB >> 15213151

egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin.

Silva Holtfreter1, Kristin Bauer, Damien Thomas, Christine Feig, Vera Lorenz, Katharina Roschack, Erika Friebe, Kathleen Selleng, Sandra Lövenich, Timm Greve, Andreas Greinacher, Brigitte Panzig, Susanne Engelmann, Gérard Lina, Barbara M Bröker.   

Abstract

PCR was employed to determine the presence of all known superantigen genes (sea, seq, and tst) and of the exotoxin-like gene cluster (set) in 40 Staphylococcus aureus isolates from blood cultures and throat swabs; 28 isolates harbored superantigen genes, five on average, and this strictly correlated with their ability to stimulate T-cell proliferation. In contrast, the set gene cluster was detected in every S. aureus strain, suggesting a nonredundant function for these genes which is different from T-cell activation. No more than 10% of normal human serum samples inhibited the T-cell stimulation elicited by egc-encoded enterotoxins (staphylococcal enterotoxins G, I, M, N, and O), whereas between 32 and 86% neutralized the classical superantigens. Similarly, intravenous human immunoglobulin G preparations inhibited egc-encoded superantigens with 10- to 100-fold-reduced potency compared with the classical enterotoxins. Thus, there are surprisingly large gaps in the capacity of human serum samples to neutralize S. aureus superantigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213151      PMCID: PMC427458          DOI: 10.1128/IAI.72.7.4061-4071.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.

Authors:  G Arad; R Levy; D Hillman; R Kaempfer
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 2.  Toxic shock syndrome and bacterial superantigens: an update.

Authors:  J K McCormick; J M Yarwood; P M Schlievert
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

3.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

4.  Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S. aureus isolates Harboring seg, seh, or sei genes.

Authors:  Katsuhiko Omoe; Machiko Ishikawa; Yu Shimoda; Dong-Liang Hu; Shigeko Ueda; Kunihiro Shinagawa
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

Review 6.  Structure and function of streptococcal and staphylococcal superantigens in septic shock.

Authors:  J Bannan; K Visvanathan; J B Zabriskie
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

7.  Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1.

Authors:  R J Williams; J M Ward; B Henderson; S Poole; B P O'Hara; M Wilson; S P Nair
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.

Authors:  M M Dinges; P M Schlievert
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  The Treatment of Severe Group A Streptococcal Infections.

Authors:  Anna Norrby-Teglund; S. Ragnar Norrby; Donald E. Low
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

10.  Superantigens: just like peptides only different.

Authors:  T Proft; J Fraser
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

View more
  53 in total

1.  A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan.

Authors:  Yoko Takizawa; Ikue Taneike; Saori Nakagawa; Tomohiro Oishi; Yoshiyuki Nitahara; Nobuhiro Iwakura; Kyoko Ozaki; Misao Takano; Teruko Nakayama; Tatsuo Yamamoto
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Clonal distribution and differential occurrence of the enterotoxin gene cluster, egc, in carriage- versus bacteremia-associated isolates of Staphylococcus aureus.

Authors:  Alex van Belkum; Damian C Melles; Susan V Snijders; Willem B van Leeuwen; Heiman F L Wertheim; Jan L Nouwen; Henri A Verbrugh; Jerome Etienne
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals.

Authors:  Tatsuo Yamamoto; Soshi Dohmae; Kohei Saito; Taketo Otsuka; Tomomi Takano; Megumi Chiba; Katsuko Fujikawa; Mayumi Tanaka
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

Review 4.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

5.  Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan.

Authors:  Tomomi Takano; Wataru Higuchi; Hassan Zaraket; Taketo Otsuka; Tatiana Baranovich; Shymaa Enany; Kohei Saito; Hirokazu Isobe; Soshi Dohmae; Kyoko Ozaki; Misao Takano; Yasuhisa Iwao; Michiko Shibuya; Takeshi Okubo; Shizuka Yabe; Da Shi; Ivan Reva; Lee-Jene Teng; Tatsuo Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

6.  Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils.

Authors:  Saotomo Itoh; Eri Hamada; Go Kamoshida; Kana Takeshita; Teruaki Oku; Tsutomu Tsuji
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

7.  Serum capacity to neutralize superantigens does not affect the outcome of Staphylococcus aureus bacteremia.

Authors:  J Yi; J S Park; K-H Hong; S-H Lee; E-C Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-31       Impact factor: 3.267

8.  Cytotoxin and pyrogenic toxin superantigen gene profiles of Staphylococcus aureus associated with subclinical mastitis in dairy cows and relationships with macrorestriction genomic profiles.

Authors:  J M Fueyo; M C Mendoza; M R Rodicio; J Muñiz; M A Alvarez; M C Martín
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.

Authors:  N J Verkaik; H A Boelens; C P de Vogel; M Tavakol; L G M Bode; H A Verbrugh; A van Belkum; W J B van Wamel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-26       Impact factor: 3.267

10.  Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar strains in isolates from children and their parents.

Authors:  Sonja Bonness; Christiane Szekat; Natalija Novak; Gabriele Bierbaum
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.